Anzeige
Mehr »
Login
Donnerstag, 06.06.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking the Wall: Uranmarkt geht wieder steil! Warum Sie hier dabei sein sollten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema DELCATH SYSTEMS

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
29.05.DELCATH SYSTEMS, INC. - 8-K, Current Report2
14.05.Earnings call: Delcath Systems targets $10M quarterly revenue in 20243
14.05.DELCATH SYSTEMS, INC. - 10-Q, Quarterly Report1
14.05.DELCATH SYSTEMS, INC. - 8-K, Current Report1
14.05.Delcath Systems Inc. Q1 Loss Beats Estimates231WASHINGTON (dpa-AFX) - Delcath Systems Inc. (DCTH) revealed Loss for first quarter that beat the Street estimates.The company's bottom line came in at -$11.11 million, or -$0.45 per share. This...
► Artikel lesen
14.05.Delcath Systems GAAP EPS of -$0.45 beats by $0.02, revenue of $3.14M beats by $0.95M2
14.05.Delcath Systems, Inc.: Delcath Systems Reports First Quarter 2024 Results and Business Highlights111Conference Call Today at 8:30 am Eastern Time QUEENSBURY, N.Y., May 14, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company...
► Artikel lesen
13.05.Delcath Systems Q1 2024 Earnings Preview2
03.05.Delcath Systems, Inc.: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)265NEW YORK, May 3, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers...
► Artikel lesen
26.04.DELCATH SYSTEMS, INC. - 8-K, Current Report1
04.04.Delcath Systems, Inc.: Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)187NEW YORK, April 4, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic...
► Artikel lesen
27.03.Earnings call: Delcath Systems charts path to $10M quarterly revenue4
26.03.Delcath Systems Inc reports results for the quarter ended in December - Earnings Summary-
26.03.DELCATH SYSTEMS, INC. - 10-K, Annual Report1
26.03.DELCATH SYSTEMS, INC. - 8-K, Current Report-
26.03.Delcath Systems GAAP EPS of -$0.48, revenue of $0.54M2
26.03.Delcath Systems, Inc.: Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update160Increases 2024 Treatment Site Activation Guidance to 20 Sites QUEENSBURY, N.Y., March 26, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional...
► Artikel lesen
25.03.Delcath Systems Q4 2023 Earnings Preview2
25.03.Earnings Preview: Delcath Systems2
21.03.Delcath Systems director buys $100k in common shares3
Seite:  Weiter >>